• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: September 26-30


ICYMI, this week we had stories about new study data on roflumilast foam for scalp and body psoriasis, dupilumab's FDA approval, the future of basal cell carcinoma treatment, and more.

POLL: How Many People in the US Have Generalized Pustular Psoriasis?

Click here to answer this week's poll.

The Mainstream Patient: September 26

This week's edition of the Mainstream Patient features stories about the best sunscreens for fall, Botox for excessive sweating, Brad Pitt's entrance into the skin care industry, and more.

New Study Data of Roflumilast Foam for Scalp and Body Psoriasis

Arcutis Biotherapeutics announced positive results from the ARRECTOR phase 3 trial.

Ruxolitinib Cream Rapidly Reduced Itch for Atopic Dermatitis in Phase 3 Study

Recent study results demonstrated a noticeable reduction in itch just 12 hours after application of ruxolitinib.

The Other JAK Inhibitors for Vitiligo

A recent review article lists six other JAK inhibitors that might be used as treatments for vitiligo in addition to ruxolitinib, the active ingredient in recently approved Opzelura.

Feds Warn of Monkeypox-Themed Malicious Email Campaign Targeting Health Care Providers

Don’t click on links or attachments unless you’re sure they are legitimate.

FDA Clears CellFX System for the Treatment of Sebaceous Hyperplasia

Pulse Biosciences' new technology will treat sebaceous hyperplasia patients with Fitzpatrick skin types I-III.

Pointers With Dr Portela: Skin Conditions with PCOS

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses common skin conditions related to polycystic ovary syndrome.

Challenges in Diagnosing Psoriasis

Expert dermatologists discuss challenges in diagnosing a patient with PsA.

Overcoming Diagnostic Delay in Psoriasis

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide tips to overcome diagnostic delay in psoriasis.

FDA Approves Dupliumab for Prurigo Nodularis

Sanofi and Regeneron’s dupliumab will provide relief to patients with extreme itch and skin lesions.

Study Reveals Psoriasis Drug May Have Cardiometabolic Benefits in Patients with Psoriatic Disease

New research finds psoriasis drug apremilast could help patients lose weight.

Preventing Misdiagnosis of Rare Skin Diseases

Thorough history taking is essential during the consultation and can help clinicians rule out other potential differential diagnoses.

Thyroid Abnormalities Rare Among Children with Vitiligo, Study Finds

The search for the causes of vitiligo continues. The findings in this study stand in contrast to another one conducted in eastern China that showed a high percentage of children with vitiligo had thyroid abnormalities.

Future of BCC

Expert dermatologists discuss future directions for the management of basal cell carcinoma.

Patient Case: 49-Year-Old Caucasian Woman With Neglected Large BCC

Sherrif F. Ibrahim, MD, PhD, presents the case of a 49-year-old White woman with neglected large basal cell carcinoma.

BCC Patient Case Impressions

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.

What's Trending in Skin Care: September 2022

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of September.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.